Eteplirsen
Generic name: Eteplirsen
Brand names: Exondys 51
Dosage form: intravenous solution (50 mg/mL)
Drug class:
Miscellaneous uncategorized agents
Usage of Eteplirsen
Eteplirsen works by helping the body produce a protein called dystrophin. Dystrophin is a protein that helps stabilize the structure of muscle tissue and is necessary for proper muscle development and function. Without dystrophin, muscle fibers can become weak and easily damaged. This can affect voluntary movement such as walking.
Children with Duchenne muscular dystrophy have a mutation of a gene that would normally cause the body to produce dystrophin.
Eteplirsen is used in children with Duchenne muscular dystrophy (DMD). Eteplirsen is not a cure for DMD, but eteplirsen may lessen muscle weakness and muscle wasting caused by this disease.
Eteplirsen was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some children responded to this medicine. However, further studies are needed to determine if eteplirsen is generally effective in treating DMD.
Eteplirsen may also be used for purposes not listed in this medication guide.
Eteplirsen side effects
Get emergency medical help if your child has signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Common side effects of eteplirsen may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Eteplirsen
Tell your child's doctor if any prior eteplirsen injections caused a severe allergic reaction in your child.
Before your child receives eteplirsen, tell the doctor about all your child's medical conditions or allergies, and all the medicines the child uses.
Although eteplirsen has been used mainly in children, it is not known whether eteplirsen could be harmful if used during pregnancy or while nursing.
Relate drugs
- Absorica
- Absorica LD
- Adakveo
- Aminohippurate sodium
- Ammonul
- Amondys 45
- Amphadase
- Amphadase injection
- Collagenase clostridium histolyticum
- Collagenase clostridium histolyticum-aaes
- Crizanlizumab
- Crizanlizumab-tmca
- Cystagon
- Cysteamine
- Cysteamine (Oral)
- Betibeglogene autotemcel
- Carbaglu
- Carglumic acid
- Casimersen
- Chlorophyllin
- Chymopapain
- Daprodustat
- Delandistrogene moxeparvovec-rokl
- Deoxycholic acid
- Derifil
- Dexrazoxane
- Dextranomer and sodium hyaluronate
- Elevidys
- Elivaldogene autotemcel
- Esbriet
- Eteplirsen
- Etranacogene dezaparvovec-drlb
- Evrysdi
- Exondys 51
- Fecal microbiota, live-jslm
- Golodirsen
- Hemgenix
- Hemin
- Hyaluronidase
- Hyaluronidase injection
- Hydase
- Hylenex
- Hylenex injection
- Jesduvroq
- Kepivance
- Kinevac
- Kybella
- Methacholine
- Nusinersen
- Nusinersen injection
- Omidubicel-onlv
- Omisirge
- Onasemnogene abeparvovec Zolgensma
- Onasemnogene abeparvovec-xioi
- Oxbryta
- Palifermin
- Palovarotene
- Panhematin
- Pirfenidone
- Plasminogen human
- Plasminogen, human-tvmh
- Procysbi
- Protirelin
- Provocholine
- Qwo
- Rebyota
- Risdiplam
- Ryplazim
- Sclerosol Intrapleural
- Sculptra
- Sincalide
- Skysona
- Sodium phenylacetate and benzoate
- Sohonos
- Spinraza
- Steritalc
- Talc
- Thyrel TRH
- Totect
- Viltepso
- Viltolarsen
- Vitrase
- Voxelotor
- Vyondys 53
- Xiaflex
- Zenatane
- Zinecard
- Zolgensma
- Zynteglo
How to use Eteplirsen
Usual Adult Dose for Muscular Dystrophy:
30 mg/kg IV once a week as an IV infusion over 35 to 60 minutes Comments:-Use a 0.2 micron in-line filter during infusion.-This drug is approved under accelerated approval based on an increase in dystrophin in skeletal muscle observed in some patients; a clinical benefit has not been established.-Continued approval may be contingent upon clinical benefit in confirmatory trials. Use: For the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping
Usual Pediatric Dose for Muscular Dystrophy:
30 mg/kg IV once a week as an IV infusion over 35 to 60 minutes Comments:-Use a 0.2 micron in-line filter during infusion.-This drug is approved under accelerated approval based on an increase in dystrophin in skeletal muscle observed in some patients; a clinical benefit has not been established.-Continued approval may be contingent upon clinical benefit in confirmatory trials. Use: For the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping
Warnings
Before your child receives eteplirsen, tell the doctor about all your child's medical conditions or allergies, and all the medicines the child uses.
What other drugs will affect Eteplirsen
Other drugs may affect eteplirsen, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your child's healthcare providers about all medicines the child uses now, and any medicine the child starts or stops using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions